Evidence map›Paper›PMID 35042906›Full record

ArticleScientific reports2022

Machine learning assisted real-time deformability cytometry of CD34+ cells allows to identify patients with myelodysplastic syndromes.

Maik Herbig, Angela Jacobi, Manja Wobus, Heike Weidner, Anna Mies, Martin Kräter, Oliver Otto, Christian Thiede, Marie-Theresa Weickert, Katharina S Götze and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Myelodysplastic Syndrome: Diagnosis and Screening.Diagnostics (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Maik HerbigBiotechnology Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Dresden, Germany.
Angela JacobiBiotechnology Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Dresden, Germany.
Manja WobusMedical Department I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
Heike WeidnerMedical Department III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
Anna MiesMedical Department I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
Martin KräterMax Planck Institute for the Science of Light & Max-Planck-Zentrum für Physik und Medizin, Erlangen, Germany.
Oliver OttoZentrum für Innovationskompetenz: Humorale Immunreaktionen in Kardiovaskulären Erkrankungen, Universität Greifswald, Greifswald, Germany.
Christian ThiedeMedical Department I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
Marie-Theresa WeickertDepartment of Medicine III: Hematology and Oncology, School of Medicine, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.
Katharina S GötzeDepartment of Medicine III: Hematology and Oncology, School of Medicine, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.
Martina RaunerMedical Department III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
Lorenz C HofbauerMedical Department III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
Martin BornhäuserMedical Department I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
Jochen GuckMax Planck Institute for the Science of Light & Max-Planck-Zentrum für Physik und Medizin, Erlangen, Germany.
Marius AderCenter for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.
Uwe Platzbecker *German Cancer Consortium (DKTK), Partner Site Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ekaterina Balaian *Medical Department I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany. Ekaterina.Balaian@uniklinikum-dresden.de.
University Hospital Carl Gustav Carus · DEMax Planck Institute for the Science of Light · DETU Dresden · DEGerman Cancer Research Center · DEHeidelberg University · DEKlinikum rechts der Isar · DETechnical University of Munich · DEUniversity Hospital Leipzig · DE

Funding

Bundesministerium für Bildung und Forschung 03Z22CN11Collaborative Research Center 655 SFB 655Deutsche Forschungsgemeinschaft 399422891Deutsche Forschungsgemeinschaft SF1243DKMS Mechthild Harf Research Grant DKMS-SLS-MHG-2016-02German Jose Carreras Leukämiestiftung DJCLS R14/18
6 · The paper itself

Abstract

Diagnosis of myelodysplastic syndrome (MDS) mainly relies on a manual assessment of the peripheral blood and bone marrow cell morphology. The WHO guidelines suggest a visual screening of 200 to 500 cells which inevitably turns the assessor blind to rare cell populations and leads to low reproducibility. Moreover, the human eye is not suited to detect shifts of cellular properties of entire populations. Hence, quantitative image analysis could improve the accuracy and reproducibility of MDS diagnosis. We used real-time deformability cytometry (RT-DC) to measure bone marrow biopsy samples of MDS patients and age-matched healthy individuals. RT-DC is a high-throughput (1000 cells/s) imaging flow cytometer capable of recording morphological and mechanical properties of single cells. Properties of single cells were quantified using automated image analysis, and machine learning was employed to discover morpho-mechanical patterns in thousands of individual cells that allow to distinguish healthy vs. MDS samples. We found that distribution properties of cell sizes differ between healthy and MDS, with MDS showing a narrower distribution of cell sizes. Furthermore, we found a strong correlation between the mechanical properties of cells and the number of disease-determining mutations, inaccessible with current diagnostic approaches. Hence, machine-learning assisted RT-DC could be a promising tool to automate sample analysis to assist experts during diagnosis or provide a scalable solution for MDS diagnosis to regions lacking sufficient medical experts.

Indexed as

Antigens, CD34Flow CytometryMachine LearningMyelodysplastic SyndromesAdultAgedAged, 80 and overBone Marrow CellsFemaleHumansMaleMiddle AgedReproducibility of ResultsAntigens, CD34

Identifiers

PMID35042906
PMCPMC8766444
OpenAlexW4206028570

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.